ReviewFrontiers in endocrinology2019

Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach.

Piera Tocci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.